tradmap

LDOS Financials Leidos

15 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 7.0% per year over the past 5 years.
  • Net income has grown faster than revenue (18.2% vs 7.0% per year).
  • Operating margin has expanded, at 12.3% in the latest year.
  • Free cash flow has grown 7.1% per year over the past 5 years.

Financial health

  • Total debt ($4.6B) exceeds cash ($1.1B); net debt is $3.5B.
  • Total debt has grown slower than revenue (-1.7% vs 7.0% per year).
  • Total debt is 1.9× EBITDA.
Revenue & net income
-$334M $8B $17B $0 2013 2015 2016 2017 2020 2021 2023 2026
RevenueNet income
Margins (gross / operating / net)
0% 9% 18% 2013 2015 2016 2017 2020 2021 2023 2026
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-32% -1% 29% 0% 2013 2015 2016 2017 2020 2021 2023 2026
ROEROA
Free cash flow (CFO − capex)
$0 $813M $2B 2013 2015 2016 2017 2020 2021 2023 2026
Free cash flow
Cash vs total debt
$0 $3B $5B 2013 2015 2016 2017 2020 2021 2023 2026
CashTotal debt
Cash flow: operating / investing / financing
-$3B -$533M $2B $0 2013 2015 2016 2017 2020 2021 2023 2026
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2026 $17.1B $1.4B 17.7% 12.3% 29.5% 10.7% $1.6B $4.6B $1.1B
2025 $16.6B $1.3B 16.4% 11.0% 28.4% 9.6% $1.3B $4.7B $849M
2023 $15.3B $199M 14.0% 4.0% 4.7% 1.6% $980M $4.7B $641M
2022 $14.3B $685M 13.8% 7.6% 15.9% 5.2% $863M $4.9B $516M
2021 $13.6B $753M 13.9% 8.5% 17.5% 5.7% $929M $5.1B $727M
2021 $12.2B $628M 13.4% 8.2% 16.3% 5.0% $1.2B — $524M
2020 $11.0B $667M 13.0% 8.3% 19.5% 7.1% $871M — $668M
2018 $10.2B $581M 14.8% 7.3% 17.6% 6.6% $695M — $327M
2017 $10.2B $366M 14.1% 5.5% 10.9% 4.1% — — $390M
2016 $7.0B $244M 13.3% 5.9% 7.8% 2.7% — — $376M
2016 — $242M — — 22.7% 7.2% — — $656M
2015 — -$323M — — -32.4% -9.8% — $1.2B $443M
2015 — -$334M — — — — — — $459M
2014 — $164M — — 10.3% 3.9% — $1.3B $430M
2013 — $525M — — 20.1% 8.9% — $1.3B $735M

Valuation over time

How the market has priced LDOS against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 57.8 115.5 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 0.7 1.5 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is LDOS growing its revenue and profit?

Over the past 5 years, Leidos's revenue has grown 7.0% per year, and net income grown 18.2% per year. These are computed facts, not advice.

How much debt does LDOS have?

As of FY2026, Leidos reported $4.6B of total debt against $1.1B of cash.

What is LDOS's profit margin?

In FY2026, gross margin was 17.7%, operating margin 12.3%, and net margin 8.5%.

What is LDOS's P/E ratio?

Leidos's P/E (TTM) is 13.15 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the LDOS stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 12.5× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.